


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31199196</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1531-2267</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Physiological genomics</Title>
                <ISOAbbreviation>Physiol. Genomics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>BMI-associated gene variants in <i>FTO</i> and cardiometabolic and brain disease: obesity or pleiotropy?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/physiolgenomics.00040.2019</ELocationID>
            <Abstract>
                <AbstractText>Obesity is a causal risk factor for the development of age-related disease conditions, which includes type 2 diabetes mellitus, cardiovascular disease, and dementia. In Genome-Wide Association studies, genetic variation in <i>FTO</i> is strongly associated with obesity, and has been described across different ethnic backgrounds and life stages. To date, much work has been devoted on determining the biological mechanisms via which <i>FTO</i> affects body weight regulation and ultimately contributes to age-related cardiometabolic and brain disease. The main hypotheses of the involved biological mechanisms include the involvement of <i>FTO</i> in habitual food intake and energy expenditure. In this narrative review, our overall aim is to provide an overview on how <i>FTO</i> gene variants could increase the risk of developing age-related disease conditions. Specifically, we will discuss the state of the literature based on the different hypotheses how <i>FTO</i> regulates body weight and ultimately contributes to cardiometabolic disease and brain disease.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ganeff</LastName>
                    <ForeName>Ingeborg Mm</ForeName>
                    <Initials>IM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leiden University Medical Center, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bos</LastName>
                    <ForeName>Maxime M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leiden University Medical Center, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Heemst</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gerontology and Geriatrics, Leiden University Medical Center, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Noordam</LastName>
                    <ForeName>Raymond</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leiden University Medical Center, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Physiol Genomics</MedlineTA>
            <NlmUniqueID>9815683</NlmUniqueID>
            <ISSNLinking>1094-8341</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FTO</Keyword>
            <Keyword MajorTopicYN="N">brain disease</Keyword>
            <Keyword MajorTopicYN="N">cardiometabolic disease</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
            <Keyword MajorTopicYN="N">pleiotropy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31199196</ArticleId>
            <ArticleId IdType="doi">10.1152/physiolgenomics.00040.2019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

